Photochromic Blockers of Voltage-Gated Potassium Channels
Light work: Studies into the mechanism of AAQ, a photoswitchable blocker of voltage‐gated K+ channels, led to the discovery and development of photochromic ligands that act at the internal tetraethylammonium binding site (see picture). These molecules can be applied from the extracellular side to im...
Saved in:
Published in | Angewandte Chemie (International ed.) Vol. 48; no. 48; pp. 9097 - 9101 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag
01.01.2009
WILEY-VCH Verlag WILEY‐VCH Verlag Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Light work: Studies into the mechanism of AAQ, a photoswitchable blocker of voltage‐gated K+ channels, led to the discovery and development of photochromic ligands that act at the internal tetraethylammonium binding site (see picture). These molecules can be applied from the extracellular side to impart long‐lasting photosensitivity on K+ channels in living cells and thereby afford photocontrol of action potential firing in neurons. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/anie.200904504 ark:/67375/WNG-2F9BMR50-7 This work was supported by a Laboratory Directed Research Development Award from the Lawrence Berkeley National Laboratory (R.H.K.), NSF-DFG grant CHE0724214 (D.T.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241; R.H.K. and D.T.), and by a grant from the Human Frontier Science Program (RGP23-2005; R.H.K. and D.T.). We thank F. Tombola and E. Isacoff for insightful discussions, the Isacoff and Yellen laboratories for Shaker clones, and T. Fehrentz for additional experiments (not included). Lawrence Berkeley National Laboratory National Institutes of Health - No. 5PN2EY018241 NSF-DFG - No. CHE0724214 istex:3A28FC4AEFB2B3EE9254A97FF9E56BB1D9445FCF Human Frontier Science Program - No. RGP23-2005 ArticleID:ANIE200904504 These authors contributed equally to this work. This work was supported by a Laboratory Directed Research Development Award from the Lawrence Berkeley National Laboratory (R.H.K.), NSF‐DFG grant CHE0724214 (D.T.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241; R.H.K. and D.T.), and by a grant from the Human Frontier Science Program (RGP23‐2005; R.H.K. and D.T.). We thank F. Tombola and E. Isacoff for insightful discussions, the Isacoff and Yellen laboratories for Shaker clones, and T. Fehrentz for additional experiments (not included). NIH RePORTER ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.200904504 |